News & Events

Neurotech Investing & Partnering Summit in Helsinki on September 7-8, 2011

After six successful years in the US, this high profile networking event for Neurotech industry will expand to Europe and take place in the Finnish capital. Meet Neurotar’s team at the venue (Grand Marina Congress Centre) or visit us at “home”, at our lab & office facility in Viikki, Helsinki.

This year’s Bio-Europe Partnering conference in Milan was a blast: 22 one-on-one meetings, 7 new partnerships for Neurotar

Most of the new partnerships are with CROs interested in developing joint service offerings or in co-marketing and co-referral arrangements. The partnerships extend our outreach to the Eastern Coast USA, to Israel, Germany, France and Japan. We have also established contacts to two potential high profile customers. Thanks to EBD group for the flawless organization […] Read more »

February 2011: Neurotar and Olympus European Microscopy Headquarters agree upon co-marketing of Neurotar’s services and of Olympus multi-photon scanning microscopy equipment

We are grateful to Olympus for ongoing support of Neurotar’s activities and for the superior quality of Olympus’ equipment, which translates into the quality of our services and into the value added to our Clients. When it comes to in vivo microscopy, Olympus remains Neurotar’s equipment manufacturer of choice, and we hope to extend our […] Read more »

Neurotar attends Bio-Europe Spring 2011 Partnering Conference in Milan on March 14-16 and presents among the Next Generation companies

On December 3, 2010, the Finnish Funding Agency for Technology and Innovation (TEKES) awards funding for Neurotar’s R&D project. The Finnish Funding Agency for Technology and Innovation announced its decision to fund the first phase of Neurotar’s Research & Development project aimed at developing Neurotar’s services in the areas of CNS and dermatology. The title […] Read more »

Neurotar attends CPhI Worldwide Expo in Paris on October 5-7, 2010

Our more than thirty meetings with prospective Clients and Partners showed that currently there is a particularly strong interest in our skin-related services. This realization motivates us to reconsider our priorities and to plan for such improvements and adjustments to our equipment that make it more suitable for experiments on skin of human subjects.

Neurotar completes first round of private financing

After approximately half-year long discussions with our long-time friends, foreign private investors, we have received their first round of financing. We are lucky to enjoy a high trust relationship with our investors, who show keen interest in Neurotar’s international growth.

More results: